Cost-Effectiveness of Left Ventricular Assist Device for Transplant-Ineligible Patients
In this economic evaluation comparing LVAD with optimal medical management, LVAD was potentially high value for most transplant-ineligible patients who are inotrope dependent. Confidence in this result was improved with plausible price reductions, yet only extreme changes rendered LVAD high value for inotrope-independent patients.
Authors
- Elisabeth M. Schaffer (ORCID: https://orcid.org/0000-0001-5193-7344)
- Rebecca Su (ORCID: https://orcid.org/0000-0002-1804-4277)
- Eric Andrew Finkelstein (ORCID: https://orcid.org/0000-0001-6443-9686)
- Junxing Chay (ORCID: https://orcid.org/0000-0002-3291-4523)
Institutions
- National University of Singapore (SG)
- Duke-NUS Medical School (SG)
- National University Health System (SG)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.4483
- Citations
- 1
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.67
Funders
- Duke-NUS Medical School